Mayo clinic launches study to uncover hidden bone marrow weakness in blood cancer patients
NCT ID NCT06536452
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how chronic lymphocytic leukemia (CLL) and its early stage, monoclonal B-cell lymphocytosis (MBL), affect the bone marrow's ability to fight infections. Researchers will compare bone marrow samples from 50 participants—including people with CLL, people with MBL, and healthy adults of similar age. The goal is to understand the differences in infection-fighting function, which may lead to better care in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?
- Can a Chemo-Free pill combo outsmart leukemia at first diagnosis?